Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acceptability and Completion of 3HP vs Standard INH for Latent TB
NCT02689089Phase 4Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Nov 2016
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rifapentine in Tuberculosis (TB), sponsored by Ottawa Hospital Research Institute. Started Nov 2016; status: completed.
02
Drugs
rifapentine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02689089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02689089.